About Me
Conditions and Treatments
Conditions
- schizophrenia
Treatments
- post covid-19 care
Learn more about conditions we treat at NYU Langone:
SchizophreniaCredentials
Positions
- Marvin Stern Professor of Psychiatry, Department of Psychiatry at NYU Grossman School of Medicine
- Vice Chair for Research, Department of Psychiatry
Board Certifications
- American Board of Psychiatry & Neurology - Psychiatry, 1986
Education and Training
- Fellowship, Tufts Medical Center, Psychiatry, 1985
- Residency, Massachusetts General Hospital, Psychiatry, 1984
Is this your profile?
Edit profileInsurance Plans Accepted
This provider accepts the following insurance plans.
-
Aetna
- Aetna EPO (AMEX employees)
- Aetna POS (American Express Employer)
-
Blue Cross Blue Shield
- BCBS EPO (BlackRock Employees)
- BCBS EPO - Empire EPO (NYU Langone Employees)
- BCBS EPO - Empire EPO (Sunset Park/Family Health Center Employees)
- BCBS EPO - Empire NYU Care (NYU Langone Employees)
- BCBS EPO - Empire NYU Care (Sunset Park/Family Health Center Employees)
- BCBS PPO (BlackRock Employees)
- BCBS PPO - Empire PPO (Sunset Park/Family Health Center Employees)
-
United Healthcare
- Unite Healthcare (NY University Care Plan)
- United Healthcare Choice (AMEX employees)
- United Healthcare Choice (Blackrock employees)
- United Healthcare Choice (CBS employees)
- United Healthcare EPO (NYU Langone Health Employees)
- United Healthcare Indemnity (NYU Langone Health Employees)
- United Healthcare Plus (NYU Langone Health Employees)
- United Healthcare Student Resources (NYU)
- United Healthcare Value, Advantage and HDHP (New York University employees)
Donald C. Goff, MD does not accept insurance.
Locations and Appointments
NYU Langone Psychiatry Associates
1 Park Avenue, 8th Floor, New York, NY 10016
Research Academic Contact
Academic office
One Park Avenue
Eighth Floor
New York, NY 10016
Phone
646-754-4843
Clinical Trials and Research Studies
-
Ultrasound Modulation of the Globus Pallidus in Schizophrenia
-
Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
-
A 12-week randomized double-blind placebo-controlled trial investigating the effects of levetiracetam in early psychosis
Publications
-
Qi, Wei; Wen, Zhenfu; Chen, Jingyun; Capichioni, Gillian; Ando, Fumika; Chen, Zhe Sage; Wang, Jijun; Yoncheva, Yuliya; Castellanos, Francisco X; Milad, Mohammed; Goff, Donald C
Schizophrenia research. 2023 Sep 14; 261:100-106
-
Qi, Wei; Marx, Julia; Zingman, Michael; Li, Yi; Petkova, Eva; Blessing, Esther; Ardekani, Babak; Sakalli Kani, Ayse; Cather, Corinne; Freudenreich, Oliver; Holt, Daphne; Zhao, Jingping; Wang, Jijun; Goff, Donald C
Schizophrenia bulletin. 2023 Jan 03; 49(1):34-42
-
Sui, Yu Veronica; McKenna, Faye; Bertisch, Hilary; Storey, Pippa; Anthopolos, Rebecca; Goff, Donald C; Samsonov, Alexey; Lazar, Mariana
Molecular psychiatry. 2022 Dec ; 27(12):5144-5153
Related News
Schizophrenia Major Risk for COVID-19 Death
Research Explores Key Factors in the Schizophrenic Brain